The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study

Hariri, Fatemeh Zahra; Moghaddam-Banaem, Lida; Bazi, Shiva Siah; Saki-Malehi, Amal; Montazeri, Ali

doi:10.1007/s00737-013-0375-6

Cited by 56 publications

(71 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The questionnaire of PSST is rated at the University of McMaster in Canada. In Iran Hariri et al (25) standardized the PSST questionnaire in Iranian population. Both the reliability and validity index for PSST questionnaire are reported 0.7 and 0.8, respectively.…”

Section: Experimental Design and Statistical Analysesmentioning

confidence: 99%

The Effect of Yoga on Women’s Premenstrual Syndrome: A Randomized Controlled Clinical Trial

Kamalifard¹,

Yavari²,

Asghari‐Jafarabadi³

et al. 2017

International Journal of Women’s Health and Reproduction Scienc

View full text Add to dashboard Cite

IntroductionWomen with premenstrual syndrome (PMS) show majority of symptoms, particularly during luteal phase, regularly every month. These symptoms are classified into 3 emotional (EM), physical (PHY) and behavioral (BE) categories (1). The common symptoms of PMS are: bloating, breast tenderness, headache, frequent urination, loss of appetite, insomnia, irritability, depression, lack of energy and increased or decreased of libido (1,2). Andrew et al (3) have shown that patients with PMS have lower work performance (27.5%), impaired working relationships (23.1%), disputation with their husbands (8.82%), relationship problems with their children (6%) and social relationship problems (41%). PMS interferes with the life of patients directly by treatment expenditures and indirectly by inefficient working hours, absenteeism and productivity (4) and requires cure and management (5). Routinely, women with PMS use pharmacological (1) and non-pharmacological approaches (6) to decrease the severity of PMS symptoms. Whereas, prescribed medications (alprazolam, progesterone, fluoxetine and gonadotropin releasing hormone) have shown side effects such as exhaustion, insomnia, headaches, menstrual dysfunction, decreased sexual ability, nausea and vomiting (1,(7)(8)(9). Recently, yoga as a safe treatment has also been introduced (10).Yoga is a Sanskrit word, meaning connection of the mind, body, emotions, logic and attention to the action. Yoga exercise is composed of physical (Asana), breathing (Pranayama) and mental (Pratt Hara) practices, resulting in health, relaxation and positive awareness. Yoga stretching practices with deep breathing and meditation strengthens muscles and protects the spine and joints of body (11). Evidences indicated that physical and mental health benefits of yoga occur through negative moderation of hypothalamic-pituitary-adrenal axis in association with sympathetic nervous system (SNS). Yoga exercise, negatively, via vagal nerves, regulates secretion of hormones (cortisol, glucose, plasma ҆ s renin, epinephrine and norepinephrine) into the bloodstream which are responsible for body functions (10). Yoga reduces the negative effects of induced stress to immune system by regulating positively the adjustment of immunoglobulin A (12). Additionally, yoga exercise reduces harmful inflammatory secretions, which make women with PMS, comfortable. Studies in India have shown positive impacts of yoga exercise on women with PMS on decreasing heart beats, blood pressure and anxiety (6,13). AbstractObjectives: Women with premenstrual syndrome (PMS) show emotional, physical and behavioral symptoms regularly every month. Mild physiological symptoms of PMS appear in 95% of women at their reproductive age. We hypothesized to evaluate the effect of yoga exercise on PMS. Materials and Methods: A randomized controlled clinical trial was conducted from April to October of 2015. Eligible women for inclusion were selected conveniently from women that had randomly referred to selected private obstetrics and gynecology clini...

show abstract

Section: Experimental Design and Statistical Analysesmentioning

confidence: 99%

The Effect of Yoga on Women’s Premenstrual Syndrome: A Randomized Controlled Clinical Trial

Kamalifard¹,

Yavari²,

Asghari‐Jafarabadi³

et al. 2017

International Journal of Women’s Health and Reproduction Scienc

View full text Add to dashboard Cite

show abstract

“…The prevalence of PMDD in Iranian females is high, and other Iranian studies report a range of PMDD prevalence rates from 13%-59%. [17,24] It is a fact that this prevalence rate is affected by cultural influences. [25] Life style is a main factor influencing PMDD in the Iranian population.…”

Section: Prevalence Of Pmddmentioning

confidence: 99%

Sleep quality in university students with premenstrual dysphoric disorder

Khazaie

Chehri

2017

Sleep Medicine

View full text Add to dashboard Cite

•Original research article• Background: Up to 8% of women in their reproductive years are affected by Premenstral Dysphoric Disorder (PMDD). Sleep disturbances such as insomnia or hypersomnia are one of the DSM-IV-TR's defining criteria for the diagnosis of PMDD and are found in about 70% of women with the disorder. However, studies are lacking that specifically address the effects of PMDD on quality of sleep. Aim: This study was designed to evaluate the prevalence of Premenstrual DysphoricDisorder (PMDD) and its impact on sleep quality in female university students. Methods: We developed an 18-item PMDD scale based on The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) to diagnose PMDD in female university studentswho ranged in age from 18 to 30 years and had regular menstrual cycles.Participants were categorized into a PMDD group or a No/PMDD group and sleep quality was compared between the two groups. The evaluation tool used to measure sleep quality was the Pittsburgh Sleep Quality Index (PSQI). Results: The prevalence of PMDD in female universitystudents was 25.5%. Analysis of the PSQI demonstrated that 80.5% of those in PMDD group had a PSQI that scored >5; however, only 56.4% in the No/ PMDD grouphad a PSQI that scored >5 (χ 2 =12.459, p<0.001). The mean PSQI score was 8.2(3.4) in the PMDD group and was 6.5(3.1) in the No/PMDD group (t=3.648, p<0.001). Conclusions: Female university students who experience PMDD are deeply affected by sleep problems. Lower sleep quality, daytime dysfunction, and sleep disturbance are common sleep problems among female university students with PMDD.

show abstract

“…This cutoff for positive screening was originally recommended by the developers of the PSST, 16 and has been followed by other investigators. 21,23 Depressive symptoms were measured using the Brazilian Portuguese-validated Patient Health Questionnaire-9 (PHQ-9). 27 PHQ-9 is a self-report questionnaire that employs the nine DSM-IV symptom-criteria for diagnosis of major depressive episodes.…”

Section: Instruments and Proceduresmentioning

confidence: 99%

“…Therefore, the PSST identifies women who would benefit from a more in-depth diagnostic interview for the diagnosis of PMDD, without the need to monitor symptoms over two reproductive cycles. 16 The PSST has been translated into and/or validated in several languages, including Spanish, 20 Persian, 21 German, 22,23 Thai, 24 Chinese, 25 and Finish. 26 In the present study, we set out to develop and validate a Brazilian Portuguese version of this instrument, including content validity, internal consistency, and test-retest reliability.…”

Section: Introductionmentioning

confidence: 99%

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Câmara

Köhler

Frey

et al. 2016

Rev. Bras. Psiquiatr.

View full text Add to dashboard Cite

Objective: To develop and validate a Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST), a questionnaire used for the screening of premenstrual syndrome (PMS) and of the most severe form of PMS, premenstrual dysphoric disorder (PMDD). The PSST also rates the impact of premenstrual symptoms on daily activities. Methods: A consecutive sample of 801 women aged X 18 years completed the study protocol. The internal consistency, test-retest reliability, and content validity of the Brazilian PSST were determined. The independent association of a positive screen for PMS or PMDD and quality of life determined by the World Health Organization Quality of Life instrument-Abbreviated version (WHOQOL-Bref) was also assessed. Results: Of 801 participants, 132 (16.5%) had a positive screening for PMDD. The Brazilian PSST had adequate internal consistency (Cronbach's alpha = 0.91) and test-retest reliability. The PSST also had adequate convergent/discriminant validity, without redundancy. Content validity ratio and content validity index were 0.61 and 0.94 respectively. Finally, a positive screen for PMS/PMDD was associated with worse WHOQOL-Bref scores. Conclusions: These findings suggest that PSST is a reliable and valid instrument to screen for PMS/ PMDD in Brazilian women.Keywords: premenstrual dysphoric disorder; mood disorders; quality of life; premenstrual symptoms screening tool; psychiatry IntroductionFemale reproductive life events are often accompanied by physical and psychological challenges associated with a negative impact on women's functioning. 1 One such example is premenstrual syndrome (PMS), a cluster of recurrent physical, psychological, and emotional symptoms occurring during the late luteal phase and disappearing within a few days of the onset of menses. [2][3][4] As many as 80% of women experience at least one of the PMS symptoms 3,5,6 described in the ICD-10, 7 which include, but are not limited to, mild psychological discomfort, feelings of bloating and weight gain, breast tenderness, swelling of hands and feet, various aches and pains, poor concentration, sleep disturbances, and changes in appetite.Moderate to severe PMS affects 20-35% of women and may cause significant functional impairment and deterioration of interpersonal relationships. 1 In turn, the prevalence of premenstrual dysphoric disorder (PMDD), the most severe form of PMS, has been estimated to vary from 3-8% among women of reproductive age. PMDD is a cyclical disorder closely related to the menstrual cycle, disappearing during pregnancy and after menopause. 8 PMDD has deleterious effects on quality of life (QOL), [9][10][11][12] with a burden similar to that of dysthymia or major depressive disorder. 13,14 The definition of PMDD in both DSM-IV and DSM-5 is based upon a peri-menstrual pattern of at least one among four key affective symptoms (markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts; marked anxiety, tension; marked affective lability; persistent anger or irritability, incr...

show abstract

The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study

Cited by 56 publications

References 18 publications

The Effect of Yoga on Women’s Premenstrual Syndrome: A Randomized Controlled Clinical Trial

The Effect of Yoga on Women’s Premenstrual Syndrome: A Randomized Controlled Clinical Trial

Sleep quality in university students with premenstrual dysphoric disorder

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Contact Info

Product

Resources

About